FDA Advisory Committee Meeting to Review MDMA-Assisted Therapy for PTSD

Lykos Therapeutics' new drug application for MDMA plus psychiatric intervention for adults with PTSD will be the first reviewed by an FDA committee for such a therapy.

Related Keywords

California ,United States ,Jennifer Mitchell ,Amy Emerson ,Drug Administration ,Advisory Committee Meeting To Review Investigational Therapy ,University Of California ,Psychopharmacologic Drugs Advisory Committee ,Lykos Therapeutics ,Sheehan Disability Scale ,Priority Review ,Accessed April ,Committee Meeting ,Review Investigational ,Assisted Therapy ,Published April ,Published December ,